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Introduction
In the past 2 decades, idiopathic polypoidal choroidal
vasculopathy (IPCV) has been recognized by ophthal-
mologists as a peculiar form of choroidal neovascu-
larization in the inner choroids. It was first described
by Yannuzzi in 1982.1 Clinically, it is characterized 
by serosanguineous retinal pigment epithelial detach-
ments (RPED) in the posterior pole and can be single
or multiple, persistent or regressed, recurrent or non-
recurrent. Previous studies have found that 7.8–23%
of patients with neovascularized age-related macular
degeneration (AMD) had PCV after evaluation by fluo-
rescein angiography (FAG) and indocyanine green
angiography (ICGA).2,3 We followed 2 Chinese pa-
tients with IPCV for >18 months and herein present
their different clinical pictures and visual outcomes.
Case Reports
Case 1
A 78-year-old man with medical history of arrhyth-
mia, hypertension, diabetes mellitus, and chronic ob-
structive pulmonary disease had suffered from blurred
vision in his right eye for a few days and came to 
our hospital. Best corrected visual acuity (BCVA) 
was 6/12 in the right eye and 6/5 in the left eye.
After complete ophthalmic examination, the anterior
segment showed only mild cataract of both eyes, 
and ophthalmoscopy revealed sensory elevation and
hemorrhagic RPED (HRPED) at the temporal-lower
juxtafoveal area in his right eye (Figure 1A). The
retina of his left eye was unremarkable. FAG revealed
fluorescence blockage (Figure 2A), and an underlying
branching choroidal vascular network was noted with
ICGA. Ultrasound B-scan and optical coherence tomo-
graphy (OCT) (Figure 2B) findings were compatible
with HRPED. The hemorrhage regressed spontane-
ously, leaving a pigmented area without any treatment
in a few months.
Five months after the initial presentation, BCVA was
6/7.5. Some old lipid pigmentation in the temporal-
lower juxtafoveal area and a new small HRPED in the
temporal-upper juxtafoveal area were noted (Figure
1B). FAG revealed no fluorescence leakage, and the
previous hemorrhagic area was flat.
Four months later, the patient complained of blur-
ring sensation in the right eye again. BCVA was 6/8.6
in the right eye and 6/5 in the left eye, and new sub-
macular HRPED and sub-RPE exudates in his right
eye were noted (Figure 1C). ICGA was performed
again and revealed a choroidal vascular network with
2 polypoid-like dilated hot spots nasal to the fovea
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(Figure 2C). FAG and OCT showed HRPED in the
right eye.
Fifteen months after the first presentation, recur-
rent HRPED in the patient’s right eye (Figure 1D) was
noted, and ICGA revealed a new polypoidal dilated
hot spot inferior to the previous polypoidal lesions
developed from the same vessel network (Figure 2D).
The hemorrhage was absorbed spontaneously 3 months
later, and final BCVA was 6/8.6 in the right eye and
6/6 in the left eye.
Case 2
An 81-year-old man with medical history of hyper-
tension and gouty arthritis had experienced sudden-
onset blurred vision and central vision distortion of
his left eye 10 years before coming to our hospital; 
his BCVA had recovered to 6/6 in his right eye and
6/7.5 in his left eye after laser therapy was performed
at another hospital.
Eight years after the first episode, he suffered from
sudden onset of vision decrease in his left eye, with
visual acuity of 6/6.7 in his right eye and 1/60 in his
left eye. Indirect ophthalmoscopy showed exudative
RPED with lipid exudates and old laser scar in the
patient’s left eye (Figure 3A) and macular drusens in
his right eye. FAG showed dye leakage that was like
the appearance of occult subretinal neovascularization
in his left eye. Transpupillary thermotherapy for his left
eye was performed twice. The HRPED and exudates
subsided, leaving a macular fibrotic scar 9 months after
the second treatment.
Ten years after first presentation, in the patient’s
recent follow-up visit, a new HRPED with extensive
diffuse exudates in the superior juxtapapillary area of
his left eye (Figure 3B) was noted. ICGA revealed a
branching choroidal vascular network and a collection
of small polypoidal dilatations of the vessels resem-
bling a cluster of grapes (Figure 3C).
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Figure 1. (A) At the first presentation, a sensory elevation and hemorrhagic retinal pigment epithelial detachment (HRPED) in the temporal-
lower juxtafoveal area was noted in the patient’s right eye. (B) Five months after the first presentation, the old hemorrhage was absorbed,
leaving a pigmented area, and a new small HRPED was noted in his right eye. (C) Nine months after the initial presentation, recurrent
HRPED in the temporal juxtafoveal area was noted. (D) Fifteen months after the initial presentation, the previous hemorrhage had been
absorbed and a new HRPED area was noted in the nasal-lower juxtafoveal area.
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Discussion
IPCV is a disease entity characterized by recurrent
serous retinal leakage and hemorrhage in the elderly
population, caused by vascular abnormalities in the
inner choroids. This disease entity was first described
by Yannuzzi in 1982.1 Kleiner and Brucker4 subse-
quently described the term “posterior uveal bleeding
syndrome” as with multiple recurrent hemorrhage or
serous fluid beneath the RPE and neurosensory retina.
In 1 previous study of PCV, Yannuzzi et al origi-
nally demonstrated a predominance of blacks, women,
bilateral involvement, and peripapillary location.2 How-
ever, in Italy, Sforzolini et al found a preponderance 
of unilateral involvement and extramacular location of
abnormal vessels in PCV patients.5 Uyama described
the preponderance of men, unilateral involvement,
and macular location of PCV in Japanese patients.6 In
2002, Kwok et al reviewed 204 Chinese patients with
a provisional diagnosis of AMD and found that the
diagnosis of 22 eyes (9.3%) could be revised to IPCV.7
The predominance of males (68.4%), unilaterality
(84.2%) and macular location of polyps (63.6%) were
the same as in Japanese. To our knowledge, the first
case of IPCV in Taiwan was reported in 2001.8 Beyond
that, case reports and the study of IPCV patients 
in Taiwan has been rare. We have presented here 2
Chinese males with IPCV with unilateral involvement,
the first 1 presented with recurrent juxtafoveal HRPED
and the second presented with peripapillary massive
serous and exudative RPED involving the fovea area.
Uyama et al observed the natural history of 14 eyes
with PCV for at least 2 years without any treatment.9
Fifty percent of the patients had a favorable course,
and the disease persisted and resulted in a poor visual
outcome in the remaining half of patients. They indi-
cated that there are 2 patterns of clinical manifesta-
tion of PCV, exudative and hemorrhagic. Theoretically,
polypoidal vascular dilations may consist of aneurysmal
dilation of vessel wall; these structures can disappear
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Figure 2. (A) At the first examination, fluorescein angiography revealed fluorescence blocked by hemorrhage; some leakage of undeter-
mined source in the late phase was noted in his right eye. (B) Optical coherence tomography was compatible with retinal pigment epithelial
detachment. (C) Indocyanine green angiography at the third episode revealed a choroidal vascular network (arrow) with 2 polypoid-like
dilatations (arrowhead) nasal to the fovea. (D) The vascular network persisted, and a new polypoidal dilated hot spot (arrow) was noted
6 months later.
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due to occlusion of the vessels by thrombus formation
within the vessels in a given area, and can grow due to
dilation of the vessel walls in other areas. Different clini-
cal manifestations may develop due to either leakage or
hemorrhage. Leakage in the vessel wall at aneurysmal
dilations leads to the exudative pattern. Hemorrhage
may derive from rupture of aneurysmal dilations, and
massive hemorrhage may derive from rupture of ve-
nules and sometimes of arteries. In our report, case 1
showed recurrent hemorrhage in the parafoveal area,
with visual acuity of 6/8.6 in his right eye during 
18 months of follow-up. In contrast, case 2, who had
a clinical picture of massive lipid exudates in the peri-
papillary area, presented a poor visual outcome, with
visual acuity of 1/60 in his left eye at 10 years after
the first presentation.
ICG angiography is the best tool available today for
the visualization of PCV. It usually shows a branching
vascular network from the choroidal circulation and
the characteristic polypoidal and aneurysmal dilations
at the terminals of branching vessels.10,11 The branching
vascular networks may last for a long period of time,
however, the polypoidal dilations at the terminals of
the network may change configuration; new dilations
grow, while others regress. Uyama et al pointed out
that there were 2 patterns of polypoidal dilations in
ICGA: (1) a large solitary round aneurysmal dilation;
and (2) a collection of small aneurysmal dilations re-
sembling a cluster of grapes.9 They also demonstrated
that patients with lesions of the first pattern had rela-
tively favorable clinical course and better visual out-
come. Lesions of the second pattern, in contrast, were
usually active and tended to bleed or leak and cause
severe visual loss. The ICGA pictures and outcomes
in our cases were similar to Uyama et al’s observation.
Case 1 had the first pattern, with relatively good visual
outcome, case 2, presenting a group of dilations re-
sembling a cluster of grapes in ICGA, had poor visual
outcome.
Clinicopathologically, Robert et al described the
dilated polypoidal lesions as large thin-walled cavernous
vascular channels without muscular layer that originated
from branches of the short posterior ciliary arteries in
a patient with IPCV undergoing enucleation.12 Both
of our 2 cases had medical history of hypertension.
Although the relationship between hypertension and
IPCV has not been well demonstrated, 1 theory is that
increased perfusion pressure secondary to hypertension
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Figure 3. (A) The patient suffered from sudden onset of blurred
vision; massive exudative retinal pigment epithelial detachment
(RPED) with lipid exudates were noted in his left eye. (B) Two years
later, a new hemorrhagic RPED (arrow) with severe exudates and
lipids in the superior juxtapapillary area was noted. (C) Indocyanine
green angiography revealed a branching vascular network and a
collection of small polypoidal dilatations of the vessels resem-
bling a cluster of grapes (arrow).
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within the arteriolar branches of the short posterior
ciliary arteries stimulates the prolapse and protrusion
of these vessels through defects or gaps in Bruch’s
membrane in the peripapillary region.
In summary, we presented 2 typical cases of IPCV
with different clinical presentations and visual outcomes
during long-term follow-up. Case 1, which can be
classified as a hemorrhagic type of IPCV, with several
recurrent large round aneurysmal dilations, had the
relatively better visual outcome. Case 2, with a collec-
tion of small aneurysmal dilations resembling a cluster
of grapes, can be classified as an exudative type of
IPCV and had a poor visual outcome. Further study of
the etiology, clinical courses, and treatments of the
different subtypes of IPCV is necessary.
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